Douglas Holtzman - 10 Feb 2022 Form 4 Insider Report for Icosavax, Inc.

Role
Chief Scientific Officer
Signature
/s/ Elizabeth Bekiroglu, Attorney-in-Fact for Douglas Holtzman
Issuer symbol
N/A
Transactions as of
10 Feb 2022
Net transactions value
$0
Form type
4
Filing time
14 Feb 2022, 18:04:32 UTC
Previous filing
02 Aug 2021
Next filing
14 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICVX Common Stock Award $0 +19,485 +6.9% $0.000000 303,633 10 Feb 2022 Direct F1, F2
transaction ICVX Common Stock Gift $0 -10,000 -19% $0.000000 42,440 31 Dec 2021 By Stanley Holtzman F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICVX Stock Option (Right to Buy) Award $0 +81,950 $0.000000 81,950 10 Feb 2022 Common Stock 81,950 $17.55 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") which will vest as to 25% of the total number of RSUs granted on each of the first four anniversaries of February 10, 2022, subject to the reporting persons continued service through the applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer and the RSUs have no expiration date.
F2 Includes 1,666 shares acquired under the Issuer's employee stock purchase plan on November 30, 2021.
F3 Douglas Holtzman, Ph.D. holds power-of-attorney (POA) over the shares owned by Stanley Holtzman. As POA, Dr. Holtzman holds voting and dispositive control over such shares. Dr. Holtzman disclaims beneficial ownership of the shares over which he has POA except to the extent of any pecuniary interest therein.
F4 25% of the shares subject to the option will vest on February 10, 2023, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the reporting person's continued service through the applicable vesting date.

Remarks:

Exhibit 24 Power of Attorney